Trial Profile

A first-in-human clinical study of BIOC51

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 28 Dec 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BIOC 51 (Primary)
Indications Cystic fibrosis
Focus Adverse reactions; First in man

Most Recent Events

28 Dec 2018 New trial record
13 Dec 2018 According to a Vast Therapeutics media release, the Company anticipates submitting an lnvestigational New Drug application and initiating First-in-Human clinical trials in 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com